Profiel
George C.
Prendergast has held several positions throughout his career.
Currently, he is the President, Chief Executive Officer & Trustee at Lankenau Institute for Medical Research since 2004.
He is also the Chief Executive Officer at LIMR Development, Inc. since 2007.
Additionally, he serves as the Chief Executive Officer of LIMR Chemical Genomics Center, Inc. Furthermore, he is the Director of Kimmel Cancer Center since 2006 and a Professor at Thomas Jefferson University since 2006.
Lastly, he holds the position of Editor-in-Chief at The Institute for Cancer Research.
In terms of education, Dr. Prendergast completed his undergraduate degree at the University of Pennsylvania in 1983.
He then pursued a graduate degree at Yale University in 1984.
Finally, he obtained his doctorate degree from Princeton University in 1989.
Actieve functies van George C. Prendergast
| Bedrijven | Functie | Begin |
|---|---|---|
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Operates as a non-profit biomedical research center | Algemeen Directeur | 01-01-2004 |
Thomas Jefferson University
Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2006 |
Kimmel Cancer Center
Kimmel Cancer Center Hospital/Nursing ManagementHealth Services Operates as cancer center | Directeur/Bestuurslid | 01-01-2006 |
LIMR Development, Inc. | Algemeen Directeur | 01-01-2007 |
LIMR Chemical Genomics Center, Inc. | Algemeen Directeur | - |
The Institute for Cancer Research
The Institute for Cancer Research Miscellaneous Commercial ServicesCommercial Services Part of The Fox Chase Cancer Center, The Institute for Cancer Research is a comprehensive cancer center committed to clinical excellence, research expertise, and community health. The center offers a broad range of nationally competitive research programs and special initiatives in cancer prevention, detection, survivorship, and community outreach. Located in Philadelphia, PA, The Institute for Cancer Research, along with the Lewis Katz School of Medicine at Temple University, conducts research on protein phosphatases to aid in the development of new cancer therapies. The company's mission is to prevail over cancer through scientific discovery, prevention, and compassionate care. | Corporate Officer/Principal | - |
Opleiding van George C. Prendergast
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Thomas Jefferson University
Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kimmel Cancer Center
Kimmel Cancer Center Hospital/Nursing ManagementHealth Services Operates as cancer center | Health Services |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Operates as a non-profit biomedical research center | Health Technology |
The Institute for Cancer Research
The Institute for Cancer Research Miscellaneous Commercial ServicesCommercial Services Part of The Fox Chase Cancer Center, The Institute for Cancer Research is a comprehensive cancer center committed to clinical excellence, research expertise, and community health. The center offers a broad range of nationally competitive research programs and special initiatives in cancer prevention, detection, survivorship, and community outreach. Located in Philadelphia, PA, The Institute for Cancer Research, along with the Lewis Katz School of Medicine at Temple University, conducts research on protein phosphatases to aid in the development of new cancer therapies. The company's mission is to prevail over cancer through scientific discovery, prevention, and compassionate care. | Commercial Services |
LIMR Development, Inc. | |
LIMR Chemical Genomics Center, Inc. |
















